16:10 ~ 16:20 |
1. Doublet Therapy Is Sufficient |
Taek Sang KIM |
|
16:20 ~ 16:30 |
2. Triplet Therapy Is The Preferred Approach |
Jong Kil NAM |
|
16:30 ~ 16:50 |
The Evolving Management of Oligometastatic Prostate Cancer |
David F. JARRARD |
|
16:50 ~ 17:10 |
De-intensification in Good Responders: Cons vs. Pros |
Patrick G. PILI? |
|
17:10 ~ 17:30 |
Degarelix: GnRH Antagonist for Advanced Hormone-dependent Prostate Cancer |
Haruna KAWANO |
|
17:30 ~ 17:50 |
Case-Based Panel Discussion |
Gyeong Eun MIN (Korea) Jae Duck CHOI (Korea) Yun-Sok HA (Korea) Sang Wook LEE (Korea) |
|